Rhythm Pharmaceuticals (RYTM) Change in Cash (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Change in Cash of $7.9 million for Q1 2026, down 53.33% year-over-year from $17.0 million in Q1 2025, and up 281.63% quarter-over-quarter from $2.1 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Change in Cash (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Change in Cash for 11 consecutive years, with $7.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 53.33% year-over-year to $7.9 million; the TTM figure through Mar 2026 stood at -$43.8 million (down 183.2% YoY), while the FY2025 annual figure was -$34.8 million, down 219.14% from the prior year.
- Change in Cash rose to $7.9 million in Q1 2026 per RYTM's latest filing, from $2.1 million in the prior quarter.
- Across five years, Change in Cash topped out at $108.2 million in Q2 2024 and bottomed at -$114.1 million in Q3 2024.
- Historically, Change in Cash has averaged $186000.0 across 5 years, with a median of $6.0 million in 2023.
- Annual changes were most pronounced in 2023 — Change in Cash plunged 193.4% — and 2024, when it jumped 1697.11%.
- Rhythm Pharmaceuticals' Change in Cash stood at -$57.4 million in 2022, then soared by 92.14% to -$4.5 million in 2023, then jumped by 1022.38% to $41.6 million in 2024, then slumped by 95.02% to $2.1 million in 2025, then jumped by 281.63% to $7.9 million in 2026.
- Business Quant data shows RYTM's Change in Cash at $7.9 million in Q1 2026, $2.1 million in Q4 2025, and -$83.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | 3.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.48 Mn |
| Mar 31, 2026 | 7.92 Mn |
| Dec 31, 2025 | 2.07 Mn |
| Sep 30, 2025 | -83.36 Mn |
| Jun 30, 2025 | 29.55 Mn |
| Mar 31, 2025 | 16.96 Mn |
| Dec 31, 2024 | 41.62 Mn |
| Sep 30, 2024 | -114.15 Mn |
| Jun 30, 2024 | 108.24 Mn |
| Mar 31, 2024 | -6.52 Mn |
| Dec 31, 2023 | -4.51 Mn |
| Sep 30, 2023 | -51.09 Mn |
| Jun 30, 2023 | 6.02 Mn |
| Mar 31, 2023 | -18.02 Mn |
| Dec 31, 2022 | -57.41 Mn |
| Sep 30, 2022 | 71.88 Mn |
| Jun 30, 2022 | 34.67 Mn |
| Mar 31, 2022 | 19.29 Mn |
| Dec 31, 2021 | -33.12 Mn |
| Sep 30, 2021 | 23.03 Mn |